mTOR inhibition by rapamycin prevents β-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes

Merav Fraenkel, Mali Ketzinel-Gilad, Yafa Ariav, Orit Pappo, Melis Karaca, Julien Castel, Marie France Berthault, Christophe Magnan, Erol Cerasi, Nurit Kaiser, Gil Leibowitz^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review